Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021753 220006063 null null Adjuvant (A) 2019-03-06 2019-04-07 null 02 null 220022911 NOT MATCHED
220021754 220006071 1.6 null Disease modification (D) 2013-08-13 2013-11-01 AML Downs haM Y N 220022988 NOT MATCHED
220021757 220006090 1.6 null Disease modification (D) null 2014-12-16 Hydroxycarbamide N N 220023007 HYDROXYCARBAMIDE
220021758 220017257 1.75 26.1 Curative (C) 2018-07-03 2018-08-07 AML MyeChild N N 220023070 NOT MATCHED
220021759 220006147 null 8.4 Palliative (P) 2016-04-07 2016-04-13 AML MyeChild 01 HD AraC N N 220023293 NOT MATCHED
220021760 220006159 null 69 Curative (C) 2013-11-15 2013-11-16 CYTARABINE N N 220023340 CYTARABINE
220021761 220006164 1.44 13.8 Curative (C) 2018-07-11 2018-09-09 AML Interim Guidelines FLA -Ida 02 N 220023346 NOT MATCHED
220021762 220013316 1.6 null Disease modification (D) 2017-12-04 2018-05-22 Hydroxycarbamide N N 220023471 HYDROXYCARBAMIDE
220021763 220017291 null 29 Curative (C) 2016-10-22 2016-12-03 null 02 N 220023478 NOT MATCHED
220021764 220006189 null 85 Adjuvant (A) 2019-03-14 2019-03-14 Hydroxycarbamide N null 220023489 HYDROXYCARBAMIDE
220021765 220006227 1.64 null null 2016-12-29 2016-12-29 CYTARABINE N N 220023640 CYTARABINE
220021766 220006230 1.68 null Disease modification (D) 2014-07-03 2014-07-03 Hydroxycarbamide N N 220023646 HYDROXYCARBAMIDE
220021767 220006241 null 79 Curative (C) 2017-02-15 2017-03-02 null 02 N 220023676 NOT MATCHED
220021768 220006249 1.66 0 Curative (C) 2018-06-28 2018-06-28 CYTARABINE N N 220023701 CYTARABINE
220021769 220006258 0 53 Palliative (P) 2014-04-06 2014-04-08 Cytarabine Low Dose 01 N 220023737 CYTARABINE
220021770 220006264 null 85 Disease modification (D) null 2016-10-10 AML Downs IT Cytarabine null null 220023759 NOT MATCHED
220021771 220006272 null 12.8 Curative (C) 2013-09-28 2013-09-28 AML Relapsed FLA - Idarubicin null N 220023793 NOT MATCHED
220021772 220006277 0 null Disease modification (D) 2015-04-15 2015-04-15 Hydroxycarbamide N N 220023811 HYDROXYCARBAMIDE
220021773 220013388 1.68 10.8 Curative (C) 2017-12-13 2018-03-15 AML MyeChild 01 IT Cyt Y N 220023821 NOT MATCHED
220021774 220006297 null 68 Palliative (P) 2019-05-20 2019-05-20 Hydroxycarbamide N N 220023866 HYDROXYCARBAMIDE
220021775 220006317 0 87.2 Disease modification (D) null 2017-06-24 Hydroxycarbamide N N 220023938 HYDROXYCARBAMIDE
220021776 220013431 null 32.1 Palliative (P) null 2017-04-02 AML Downs HD Cytarabine (3+4) N null 220024098 NOT MATCHED
220021778 220021445 null 68 Disease modification (D) 2016-01-24 2016-03-15 Hydroxycarbamide 02 N 220024326 HYDROXYCARBAMIDE
220021779 220006408 null 71.4 Curative (C) 2015-11-14 2015-11-17 Rituximab N null 220024353 RITUXIMAB
220021781 220006423 1.62 null Curative (C) 2014-05-07 2014-05-07 Alemtuz+Fludara+Melphalan RIC MUD N N 220024416 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021782 220006429 1.74 83.7 Curative (C) 2018-11-17 2018-12-16 Rituximab N N 220024432 RITUXIMAB
220021784 220006443 1.6 57 Curative (C) 2014-11-01 2014-11-08 Alemtuz+Fludara+Melphalan RIC MUD N null 220024482 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021785 220006445 1.79 74 Curative (C) 2016-01-14 2016-01-14 AML 18 TRIAL null N 220024501 AML18 TRIAL
220021786 220020764 1.56 71.4 Disease modification (D) null 2018-08-29 Rituximab N N 220024528 RITUXIMAB
220021787 220013541 1.74 73 Curative (C) 2014-10-18 2014-11-15 Alemtuz+Fludara+Melphalan RIC MUD N N 220024689 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021788 220022253 null 106 Disease modification (D) 2019-04-29 2019-04-29 Dasatinib N N 220024708 DASATINIB
220021789 220021452 1.85 84.2 Curative (C) 2013-06-01 2013-06-01 AML18 PILOT TRIAL N N 220024810 PILOT TRIAL
220021790 220022340 1.68 53 Curative (C) 2015-12-22 2015-12-22 Rituximab 2 N 220024847 RITUXIMAB
220021792 220013586 null null Adjuvant (A) 2014-07-27 2016-08-09 Dasatinib N N 220025121 DASATINIB
220021793 220013613 1.77 87.5 Curative (C) 2016-08-24 2016-08-26 Alemtuz+Fludara+Melphalan RIC MUD N N 220025353 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021794 220019557 1.62 44.4 Curative (C) 2015-12-25 2016-04-01 AML 18 TRIAL Y N 220025361 AML18 TRIAL
220021795 220013630 null 90 null 2016-02-12 2016-02-12 Rituximab (Maintenance) N N 220025425 RITUXIMAB
220021796 220006686 0 71.8 Curative (C) 2019-05-05 2019-07-23 AML 18 TRIAL N N 220025668 AML18 TRIAL
220021797 220006748 1.6 0 null null 2015-11-15 AML18 PILOT TRIAL N N 220025945 PILOT TRIAL
220021798 220006778 1.72 85 Curative (C) 2014-01-30 2014-11-22 Dasatinib N N 220026051 DASATINIB
220021799 220006794 1.56 91 Curative (C) 2019-08-22 2019-11-06 Alemtuz+Fludara+Melphalan RIC MUD N N 220026127 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021800 220006798 1.72 103.8 Curative (C) 2017-08-08 2017-08-25 Rituximab null N 220026128 RITUXIMAB
220021801 220006805 1.6 119 Curative (C) null 2015-10-16 Alemtuz+Fludara+Melphalan RIC MUD N N 220026157 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021802 220006820 1.55 null Palliative (P) 2019-08-10 2019-08-10 Dasatinib 02 N 220026210 DASATINIB
220021803 220006847 1.52 74.8 Curative (C) 2017-08-25 2017-11-25 AML 18 TRIAL Y N 220026282 AML18 TRIAL
220021804 220006879 1.63 50 Curative (C) 2018-10-24 2018-10-24 Rituximab 2 N 220026364 RITUXIMAB
220021805 220006920 1.94 75 Palliative (P) 2017-10-28 2017-12-11 Dasatinib N N 220026565 DASATINIB
220021806 220006930 1.63 59.6 Curative (C) 2017-12-05 2018-01-04 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220026587 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021807 220006963 null 93.3 Disease modification (D) 2014-12-16 2014-12-16 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220026693 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220021808 220007006 null 83.3 Curative (C) 2016-09-04 2016-10-17 AML 18 Pilot Trial N N 220026840 PILOT TRIAL